» Articles » PMID: 23093619

Intraperitoneal Influx of Neutrophils in Response to IL-33 is Mast Cell-dependent

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2012 Oct 25
PMID 23093619
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

IL-33 is a recently discovered cytokine involved in induction of Th2 responses and functions as an alarmin. Despite numerous recent studies targeting IL-33, its role in vivo is incompletely understood. Here we investigated inflammatory responses to intraperitoneal IL-33 injections in wild-type and mast cell-deficient mice. We found that wild-type mice, but not mast cell-deficient W(sh)/W(sh) mice, respond to IL-33 treatment with neutrophil infiltration to the peritoneum, whereas other investigated cell types remained unchanged. In W(sh)/W(sh) mice, the IL-33-induced innate neutrophil response could be rescued by local reconstitution with wild-type but not with T1/ST2(-/-) mast cells, demonstrating a mast cell-dependent mechanism. Furthermore, we found this mechanism to be partially dependent on mast cell-derived TNF, as we observed reduced neutrophil infiltration in W(sh)/W(sh) mice reconstituted with TNF(-/-) bone marrow-derived mast cells compared with those reconstituted with wild-type bone marrow-derived mast cells. In agreement with our in vivo findings, we demonstrate that human neutrophils migrate toward the supernatant of IL-33-treated human mast cells. Taken together, our findings reveal that IL-33 activates mast cells in vivo to recruit neutrophils, a mechanism dependent on IL-33R expression on peritoneal mast cells. Mast cells activated in vivo by IL-33 probably play an important role in inflammatory reactions.

Citing Articles

Type 2 immunity in allergic diseases.

Ogulur I, Mitamura Y, Yazici D, Pat Y, Ardicli S, Li M Cell Mol Immunol. 2025; 22(3):211-242.

PMID: 39962262 PMC: 11868591. DOI: 10.1038/s41423-025-01261-2.


IL-10 Differentially Promotes Mast Cell Responsiveness to IL-33, Resulting in Enhancement of Type 2 Inflammation and Suppression of Neutrophilia.

Ranjitkar S, Krajewski D, Garcia C, Tedeschi C, Polukort S, Rovatti J J Immunol. 2024; 212(9):1407-1419.

PMID: 38497670 PMC: 11018500. DOI: 10.4049/jimmunol.2300884.


CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17.

Cavagnero K, Li F, Dokoshi T, Nakatsuji T, ONeill A, Aguilera C J Exp Med. 2024; 221(4).

PMID: 38393304 PMC: 10890925. DOI: 10.1084/jem.20231425.


IL-33 Induces Cellular and Exosomal miR-146a Expression as a Feedback Inhibitor of Mast Cell Function.

Taruselli M, Abdul Qayum A, Abebayehu D, Caslin H, Dailey J, Kotha A J Immunol. 2024; 212(8):1277-1286.

PMID: 38381001 PMC: 10984763. DOI: 10.4049/jimmunol.2200916.


ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma.

Luu Quoc Q, Cao T, Jang J, Shin Y, Choi Y, Park H Allergy Asthma Immunol Res. 2024; 16(1):22-41.

PMID: 38262389 PMC: 10823144. DOI: 10.4168/aair.2024.16.1.22.